-
Something wrong with this record ?
Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMA
NM. Selby, PJ. Blankestijn, P. Boor, C. Combe, KU. Eckardt, E. Eikefjord, N. Garcia-Fernandez, X. Golay, I. Gordon, N. Grenier, PD. Hockings, JD. Jensen, JA. Joles, PA. Kalra, BK. Krämer, PB. Mark, IA. Mendichovszky, O. Nikolic, A. Odudu, ACM....
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 1996 to 1 year ago
Open Access Digital Library
from 1996-01-01
PubMed
30137584
DOI
10.1093/ndt/gfy152
Knihovny.cz E-resources
- MeSH
- Biomarkers analysis MeSH
- Renal Insufficiency, Chronic classification pathology therapy MeSH
- Humans MeSH
- Magnetic Resonance Imaging methods MeSH
- Disease Progression MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Functional renal magnetic resonance imaging (MRI) has seen a number of recent advances, and techniques are now available that can generate quantitative imaging biomarkers with the potential to improve the management of kidney disease. Such biomarkers are sensitive to changes in renal blood flow, tissue perfusion, oxygenation and microstructure (including inflammation and fibrosis), processes that are important in a range of renal diseases including chronic kidney disease. However, several challenges remain to move these techniques towards clinical adoption, from technical validation through biological and clinical validation, to demonstration of cost-effectiveness and regulatory qualification. To address these challenges, the European Cooperation in Science and Technology Action PARENCHIMA was initiated in early 2017. PARENCHIMA is a multidisciplinary pan-European network with an overarching aim of eliminating the main barriers to the broader evaluation, commercial exploitation and clinical use of renal MRI biomarkers. This position paper lays out PARENCHIMA's vision on key clinical questions that MRI must address to become more widely used in patients with kidney disease, first within research settings and ultimately in clinical practice. We then present a series of practical recommendations to accelerate the study and translation of these techniques.
Antaros Medical BioVenture Hub Mölndal Sweden
Centre for Kidney Research and Innovation University of Nottingham UK
Department of Health and Functioning Western Norway University of Applied Sciences Norway
Departments of Renal and Clinical Medicine Aarhus University Hospital Aarhus Denmark
Faculty of Medicine University of Novi Sad Center of Radiology Clinical Centre of Vojvodina Serbia
Great Ormond Street Institute of Child Health University College London London UK
Institute of Cardiovascular and Medical Sciences University of Glasgow Glasgow UK
Institute of Neurology University College London Queen Square London UK
Institute of Pathology and Department of Nephrology RWTH University Aachen Germany
IRCCS Istituto di Ricerche Farmacologiche Mario Negri Bergamo Italy
Nephrology and Hypertension IIS Fundacion Jimenez Diaz UAM Madrid Spain
Nephrology and Hypertension University Medical Center Utrecht Utrecht The Netherlands
Radiology Department Geneva University Hospital and University of Geneva Geneva Switzerland
Service of Nephrology Clinica Universidad de Navarra Pamplona Spain
University of Bern Inselspital Bern Switzerland HFR Fribourg Hôpital Cantonal Fribourg Switzerland
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045284
- 003
- CZ-PrNML
- 005
- 20241009144657.0
- 007
- ta
- 008
- 200109s2018 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/ndt/gfy152 $2 doi
- 035 __
- $a (PubMed)30137584
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Selby, Nicholas M $u Centre for Kidney Research and Innovation, University of Nottingham, UK.
- 245 10
- $a Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMA / $c NM. Selby, PJ. Blankestijn, P. Boor, C. Combe, KU. Eckardt, E. Eikefjord, N. Garcia-Fernandez, X. Golay, I. Gordon, N. Grenier, PD. Hockings, JD. Jensen, JA. Joles, PA. Kalra, BK. Krämer, PB. Mark, IA. Mendichovszky, O. Nikolic, A. Odudu, ACM. Ong, A. Ortiz, M. Pruijm, G. Remuzzi, J. Rørvik, S. de Seigneux, RJ. Simms, J. Slatinska, P. Summers, MW. Taal, HC. Thoeny, JP. Vallée, M. Wolf, A. Caroli, S. Sourbron,
- 520 9_
- $a Functional renal magnetic resonance imaging (MRI) has seen a number of recent advances, and techniques are now available that can generate quantitative imaging biomarkers with the potential to improve the management of kidney disease. Such biomarkers are sensitive to changes in renal blood flow, tissue perfusion, oxygenation and microstructure (including inflammation and fibrosis), processes that are important in a range of renal diseases including chronic kidney disease. However, several challenges remain to move these techniques towards clinical adoption, from technical validation through biological and clinical validation, to demonstration of cost-effectiveness and regulatory qualification. To address these challenges, the European Cooperation in Science and Technology Action PARENCHIMA was initiated in early 2017. PARENCHIMA is a multidisciplinary pan-European network with an overarching aim of eliminating the main barriers to the broader evaluation, commercial exploitation and clinical use of renal MRI biomarkers. This position paper lays out PARENCHIMA's vision on key clinical questions that MRI must address to become more widely used in patients with kidney disease, first within research settings and ultimately in clinical practice. We then present a series of practical recommendations to accelerate the study and translation of these techniques.
- 650 _2
- $a biologické markery $x analýza $7 D015415
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a magnetická rezonanční tomografie $x metody $7 D008279
- 650 _2
- $a chronická renální insuficience $x klasifikace $x patologie $x terapie $7 D051436
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Blankestijn, Peter J $u Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.
- 700 1_
- $a Boor, Peter, $d 1979- $u Institute of Pathology and Department of Nephrology, RWTH University, Aachen, Germany. $7 xx0323557
- 700 1_
- $a Combe, Christian $u Service de Néphrologie Transplantation Dialyse Aphérèse, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
- 700 1_
- $a Eckardt, Kai-Uwe $u Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany.
- 700 1_
- $a Eikefjord, Eli $u Department of Health and Functioning, Western Norway University of Applied Sciences, Norway.
- 700 1_
- $a Garcia-Fernandez, Nuria $u Service of Nephrology, Clinica Universidad de Navarra, Pamplona, Spain.
- 700 1_
- $a Golay, Xavier $u Institute of Neurology, University College London, Queen Square, London, UK.
- 700 1_
- $a Gordon, Isky $u Great Ormond Street Institute of Child Health, University College London, London, UK.
- 700 1_
- $a Grenier, Nicolas $u Service d'Imagerie Diagnostique et Interventionnelle de l'Adulte, Centre Hospitalier Universitaire de Bordeaux Place Amelie Raba-Leon, Bordeaux, France.
- 700 1_
- $a Hockings, Paul D $u Antaros Medical, BioVenture Hub, Mölndal, Sweden.
- 700 1_
- $a Jensen, Jens D $u Departments of Renal and Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.
- 700 1_
- $a Joles, Jaap A $u Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.
- 700 1_
- $a Kalra, Philip A $u Department of Renal Medicine, Salford Royal Hospital and Division of Cardiovascular Sciences, University of Manchester, Manchester, UK.
- 700 1_
- $a Krämer, Bernhard K $u Vth Department of Medicine, University Medical Center Mannheim, Medical Faculty Mannheim of the University Heidelberg, Mannheim, Germany.
- 700 1_
- $a Mark, Patrick B $u Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
- 700 1_
- $a Mendichovszky, Iosif A $u Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, UK.
- 700 1_
- $a Nikolic, Olivera $u Faculty of Medicine,University of Novi Sad, Center of Radiology, Clinical Centre of Vojvodina, Serbia.
- 700 1_
- $a Odudu, Aghogho $u Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
- 700 1_
- $a Ong, Albert C M $u Academic Nephrology Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, UK.
- 700 1_
- $a Ortiz, Alberto $u Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain.
- 700 1_
- $a Pruijm, Menno $u Service of Nephrology and Hypertension, Department of Medicine, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
- 700 1_
- $a Remuzzi, Giuseppe $u IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Bergamo, Italy.
- 700 1_
- $a Rørvik, Jarle $u Department of Clinical Medicine, University of Bergen, Bergen, Norway. Department of Radiology, Haukeland University Hospital, Bergen, Norway.
- 700 1_
- $a de Seigneux, Sophie $u Service of Nephrology, Department of Medicine Specialties, University Hospital of Geneva, Geneva, Switzerland.
- 700 1_
- $a Simms, Roslyn J $u Academic Nephrology Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, Sheffield, UK.
- 700 1_
- $a Slatinska, Janka $u Department of Nephrology, Transplant Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Summers, Paul $u Department of Medical Imaging and Radiation Sciences, Radiology Division, European Institute of Oncology (IEO), Milan, Italy. QMRI Tech iSrl, Piazza dei Martiri Pennesi 20, Pescara, Italy.
- 700 1_
- $a Taal, Maarten W $u Centre for Kidney Research and Innovation, University of Nottingham, UK.
- 700 1_
- $a Thoeny, Harriet C $u University of Bern, Inselspital, Bern, Switzerland. HFR Fribourg, Hôpital Cantonal, Fribourg, Switzerland.
- 700 1_
- $a Vallée, Jean-Paul $u Radiology Department, Geneva University Hospital and University of Geneva, Geneva, Switzerland.
- 700 1_
- $a Wolf, Marcos $u Center for Medical Physics and Biomedical Engineering, MR-Centre of Excellence, Medical University of Vienna, Vienna, Austria.
- 700 1_
- $a Caroli, Anna $u IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Bergamo, Italy.
- 700 1_
- $a Sourbron, Steven $u Leeds Imaging Biomarkers Group, Department of Biomedical Imaging Sciences, University of Leeds, Leeds, UK.
- 773 0_
- $w MED00010288 $t Nephrology, dialysis, transplantation $x 1460-2385 $g Roč. 33, suppl_2 (2018), s. ii4-ii14
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30137584 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20241009144652 $b ABA008
- 999 __
- $a ok $b bmc $g 1483553 $s 1083957
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 33 $c suppl_2 $d ii4-ii14 $e 20180901 $i 1460-2385 $m Nephrology, dialysis, transplantation $n Nephrol Dial Transplant $x MED00010288
- LZP __
- $a Pubmed-20200109
